Is amoxicillin-clavulanate potassium effective for treating urinary tract infections (UTIs) in Europe?

Amoxicillin-clavulanate for UTI explained: antibiotic spectrum, resistance patterns, dosing considerations, and prescribing criteria.

In this episode, we examine when co-amoxiclav (amoxicillin with clavulanic acid) may be used for urinary tract infections and how suitability is assessed under EU clinical guidance.

You’ll learn:

• How amoxicillin-clavulanate works against certain bacterial UTIs

• Why it is not always first-line for uncomplicated cystitis

• The role of urine culture and sensitivity testing

• Typical dosing considerations and treatment duration

• Common side effects, including gastrointestinal upset

• Risks of antibiotic resistance and inappropriate use

• Situations where an antibiotic request may be declined pending laboratory confirmation

We explain how doctors assess symptom severity, pregnancy status, recurrence history, allergy profile, local resistance data, and red flag signs such as fever or flank pain during an online consultation in the EU. Not all UTIs require the same antibiotic, and targeted therapy is preferred when possible.

This episode reflects the clinical standards used by Mobi Doctor, where infection-related consultations are reviewed by a registered physician in line with EU prescribing guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/treating-urinary-tract-infections-with-amoxicillin-clavulanate-potassium